H.R. 5587 · 116th Congress
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
- Stage
- In committee
- Sponsor
- Collin Peterson
- Introduced
- 2020-01-13
- Latest action
- 2020-01-23 · Referred to the Subcommittee on Biotechnology, Horticulture, and Research.
Summary
This bill requires the Food and Drug Administration to regulate a hemp-derived cannabidiol (CBD) product as a dietary supplement instead of as a drug. The bill also allows the introduction into interstate commerce of a food with added hemp-derived CBD.
The Department of Agriculture must report on market and regulatory barriers for producers operating under its domestic hemp production program.